Analysis: Positioning to Benefit within Webster Financial, Integra LifeSciences, OSI, Tivity Health, LCI Industries, and TrueCar — Research Highlights Growth, Revenue, and Consolidated Results

Analysis: Positioning to Benefit within Webster Financial, Integra LifeSciences, OSI, Tivity Health, LCI Industries, and TrueCar — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Webster Financial Corporation (NYSE:WBS), Integra LifeSciences Holdings Corporation (NASDAQ:IART), OSI Systems, Inc. (NASDAQ:OSIS), Tivity Health, Inc. (NASDAQ:TVTY), LCI Industries (NYSE:LCII), and TrueCar, Inc. (NASDAQ:TRUE), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

WBS DOWNLOAD: http://Fundamental-Markets.com/register/?so=WBS
IART DOWNLOAD:
http://Fundamental-Markets.com/register/?so=IART
OSIS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=OSIS
TVTY DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TVTY
LCII DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LCII
TRUE DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TRUE

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Webster Financial Corporation (NYSE:WBS), Integra LifeSciences Holdings Corporation (NASDAQ:IART), OSI Systems, Inc. (NASDAQ:OSIS), Tivity Health, Inc. (NASDAQ:TVTY), LCI Industries (NYSE:LCII), and TrueCar, Inc. (NASDAQ:TRUE) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 15th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

WEBSTER FINANCIAL CORPORATION (WBS) REPORT OVERVIEW

Webster Financial's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Webster Financial reported interest income of $245.92MM vs $219.68MM (up 11.95%) and basic earnings per share $0.85 vs $0.62 (up 37.10%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Webster Financial reported interest income of $913.61MM vs $821.91MM (up 11.16%) and basic earnings per share $2.68 vs $2.17 (up 23.50%). Webster Financial is expected to report earnings on July 20th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.64. The estimated EPS forecast for the next fiscal year is $3.92 and is expected to report on January 22nd, 2019.

To read the full Webster Financial Corporation (WBS) report, download it here: http://Fundamental-Markets.com/register/?so=WBS

-----------------------------------------

INTEGRA LIFESCIENCES HOLDINGS CORPORATION (IART) REPORT OVERVIEW

Integra LifeSciences' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Integra LifeSciences reported revenue of $357.08MM vs $258.64MM (up 38.06%) and basic earnings per share $0.14 vs $0.09 (up 55.56%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Integra LifeSciences reported revenue of $1,188.24MM vs $992.08MM (up 19.77%) and basic earnings per share $0.84 vs $1.00 (down 16.00%). Integra LifeSciences is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.45. The estimated EPS forecast for the next fiscal year is $2.74 and is expected to report on February 26th, 2019.

To read the full Integra LifeSciences Holdings Corporation (IART) report, download it here: http://Fundamental-Markets.com/register/?so=IART

-----------------------------------------

OSI SYSTEMS, INC. (OSIS) REPORT OVERVIEW

OSI's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, OSI reported revenue of $267.30MM vs $245.15MM (up 9.04%) and basic earnings per share $0.14 vs $0.74 (down 81.08%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, OSI reported revenue of $960.95MM vs $829.66MM (up 15.82%) and basic earnings per share $1.12 vs $1.35 (down 17.04%). OSI is expected to report earnings on August 23rd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.02.

To read the full OSI Systems, Inc. (OSIS) report, download it here: http://Fundamental-Markets.com/register/?so=OSIS

-----------------------------------------

TIVITY HEALTH, INC. (TVTY) REPORT OVERVIEW

Tivity Health's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Tivity Health reported revenue of $149.93MM vs $140.97MM (up 6.36%) and basic earnings per share $0.54 vs $0.39 (up 38.46%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tivity Health reported revenue of $556.94MM vs $501.00MM (up 11.17%) and basic earnings per share $1.62 vs -$3.49. Tivity Health is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $2.43 and is expected to report on February 28th, 2019.

To read the full Tivity Health, Inc. (TVTY) report, download it here: http://Fundamental-Markets.com/register/?so=TVTY

-----------------------------------------

LCI INDUSTRIES (LCII) REPORT OVERVIEW

LCI Industries' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, LCI Industries reported revenue of $650.49MM vs $498.34MM (up 30.53%) and basic earnings per share $1.88 vs $1.73 (up 8.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, LCI Industries reported revenue of $2,147.77MM vs $1,678.90MM (up 27.93%) and basic earnings per share $5.31 vs $5.26 (up 0.95%). LCI Industries is expected to report earnings on August 3rd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.59. The estimated EPS forecast for the next fiscal year is $8.40 and is expected to report on February 14th, 2019.

To read the full LCI Industries (LCII) report, download it here: http://Fundamental-Markets.com/register/?so=LCII

-----------------------------------------

TRUECAR, INC. (TRUE) REPORT OVERVIEW

TrueCar's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, TrueCar reported revenue of $81.06MM vs $75.76MM (up 7.00%) and basic earnings per share -$0.09 vs -$0.08. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TrueCar reported revenue of $323.15MM vs $277.51MM (up 16.45%) and basic earnings per share -$0.35 vs -$0.49. TrueCar is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.18 and is expected to report on February 21st, 2019.

To read the full TrueCar, Inc. (TRUE) report, download it here: http://Fundamental-Markets.com/register/?so=TRUE

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.